Command Palette

Search for a command to run...

Clinical Trials · NCT06042153

DIALYSIS-TIR Study

Active Not RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Active Not Recruiting
Sponsor
University of Texas Southwestern Medical Center
Enrollment
43
Start date
Dec 2023
Locations
5 sites, United States
Primary endpoint
Change in TIR (70-180 mg/dl)
View Semaglutide compound reference